MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
about
Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System MalignanciesTargeting immune checkpoints in malignant gliomaMicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cellsEpi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacyMicroRNA and extracellular vesicles in glioblastoma: small but powerful.Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling.Serum microRNA profiling in patients with glioblastoma: a survival analysis.MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma.MicroRNAs provide a novel pathway toward combinatorial immune checkpoint blockade.Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade.Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy.MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47.The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy.Methylation-induced downregulation and tumor-suppressive role of microRNA-98 in glioma through targeting Sal-like protein 4.Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.Immune checkpoint therapy in liver cancer.Key questions about the checkpoint blockade-are microRNAs an answer?DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.MicroRNAs and immunity in periodontal health and diseaseControl of Immunoregulatory Molecules by miRNAs in T Cell ActivationMicroRNA-129-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting DNMT3AMicroRNAs: Pleiotropic Regulators in the Tumor Microenvironment
P2860
Q28072007-EF769F9E-83DB-4C41-8082-3A403DAF8404Q28072012-18E57CD8-D503-4D60-8BAD-2DEBC7BD4D12Q37147870-A44001E8-7A28-4987-8C60-A675FBD9228EQ38749824-F9D1B726-D6F0-4836-B482-19ED35E203CCQ38770220-C3535B51-3C28-4986-A1A4-A37A071434BBQ39045550-5A18B1E0-FF9B-44A7-A052-76A41AA317F4Q39108144-223DF451-601E-4400-A8A9-8A78BD30E522Q41672599-77C805A0-7D3F-420D-8C6F-DBFC5C33680BQ42317085-F1BA5DA6-D70B-4C54-855C-D4729C49DB64Q42376351-2FA3A7BC-ADA0-419E-9861-5BB335EC9785Q42908552-3B2E5CDE-30D9-4310-B342-A51F2A87353DQ47135020-A5FBD3AD-C33B-4A5F-9B85-B217585498BAQ47767814-E5B7A3E8-B430-4780-B90E-FE3F245BEC59Q48524068-B3FF98C6-182E-4CCF-84D5-513FA9661871Q49463699-6AA9FEB5-D753-484F-ADB6-8C2869E3A058Q50045047-F871F8DD-7BDD-4974-8971-18237243FE7BQ54218762-FDD6C6F4-C584-43BA-A7A4-990317D96C02Q55008806-375BBFA2-292A-4397-A5E8-397DB9E203A4Q55339993-C8786AF6-6937-410D-9421-52D5E133AB2BQ55425717-98E5DEE0-4767-43E9-B651-E9C1C2DFE569Q57170593-162ACBC6-425A-45DD-85AC-3F540A43E194Q57492030-33F5FF8C-CE68-4C83-B6F7-1C597B368521Q57493383-A89C98D8-9BE7-4386-BCE3-C836A72F89E0Q59137767-2EBEE1E9-1797-479C-AFEA-F646CE400541
P2860
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
@en
type
label
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
@en
prefLabel
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
@en
P2093
P2860
P50
P356
P1433
P1476
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
@en
P2093
Amy B Heimberger
Konrad Gabrusiewicz
Ling-Yuan Kong
Mark R Gilbert
Neal Huang
Shouhao Zhou
Willem Overwijk
P2860
P304
P356
10.1093/NEUONC/NOV292
P577
2015-12-11T00:00:00Z